+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bioanalytical Testing Services Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 140 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5912046
The global bioanalytical testing services market size reached US$ 2.8 Billion in 2022. Looking forward, the market is expected to reach US$ 5.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2022-2028.

Bioanalytical testing services are used for the quantitative determination of drugs concentration and their metabolites and pharmacodynamic biomarkers in biological fluids. These services include method validation for ensuring results that demonstrate accuracy, precision, selectivity, and stability and assure the accuracy of sample analysis results. Nowadays, they rely on developed and validated methods for detecting analytes and metabolites in a diversity of complex biological matrices. Some of these matrices are urine, serum, blood, saliva, plasma, breast milk, cell lysates, cell culture media, tissue homogenates, cerebrospinal fluid (CSF), and wastewater from pharmaceutical production.

Bioanalytical Testing Services Market Trends

The increasing occurrence of chronic health conditions worldwide on account of sedentary lifestyles and increasing consumption of fast food, along with the rising preferences for personalized medical treatments, represents one of the key factors influencing the market positively. Additionally, biopharmaceutical companies are using bioanalytical testing services for validation of assays and drug development at both preclinical and clinical stages. Moreover, the global transmission of the coronavirus disease (COVID-19) and the lack of effective vaccines and treatments are driving the need for widespread screening and early detection. This has increased the usage of bioanalytical testing services for point-of-care (POC) diagnostic and controlling the spread and minimizing the resultant health and societal impact of the infection. Apart from this, several companies are incorporating a wide range of innovative techniques to offer rapid high-volume analyses. These techniques generally include mass spectrometry, immunochemistry, Ultra-Performance Liquid Chromatography (UPLC), automated sample preparation using robotics or turbulent flow, and large sample storage combined with bar code systems. This, in confluence with the improving healthcare infrastructure, is strengthening the growth of the market.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global bioanalytical testing services market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on molecule type, test type and workflow.

Breakup by Molecule Type:

  • Small Molecule
  • Large Molecule
  • LC-MS Studies
  • Immunoassays

Breakup by Test Type:

  • ADME
  • In-Vivo
  • In-Vitro
  • PK
  • PD
  • Bioavailability
  • Bioequivalence

Breakup by Workflow:

  • Sample Preparation
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
  • Sample Analysis
  • Hyphenated Technique
  • Chromatographic Technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape


The competitive landscape of the industry has also been examined along with the profiles of the key players being Almac Group, Charles River Laboratories International Inc., Frontage Laboratories Inc., ICON plc, Intertek Group plc, Laboratory Corporation of America Holdings, Pace Analytical Services LLC, PPD Inc., PRA Health Sciences, SGS SA, Syneos Health and Toxikon Corporation.

Key Questions Answered in This Report

1. What was the size of the global bioanalytical testing services market in 2022?
2. What is the expected growth rate of the global bioanalytical testing services market during 2023-2028?
3. What has been the impact of COVID-19 on the global bioanalytical testing services market?
4. What are the key factors driving the global bioanalytical testing services market?
5. What is the breakup of the global bioanalytical testing services market based on the molecule type?
6. What is the breakup of the global bioanalytical testing services market based on the test type?
7. What is the breakup of the global bioanalytical testing services market based on the workflow?
8. What are the key regions in the global bioanalytical testing services market?
9. Who are the key players/companies in the global bioanalytical testing services market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bioanalytical Testing Services Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Molecule Type
6.1 Small Molecule
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Large Molecule
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 LC-MS Studies
6.2.2.2 Immunoassays
6.2.2.3 Others
6.2.3 Market Forecast
7 Market Breakup by Test Type
7.1 ADME
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 In-Vivo
7.1.2.2 In-Vitro
7.1.3 Market Forecast
7.2 PK
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 PD
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Bioavailability
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Bioequivalence
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Workflow
8.1 Sample Preparation
8.1.1 Market Trends
8.1.2 Key Segments
8.1.2.1 Protein Precipitation
8.1.2.2 Liquid-Liquid Extraction
8.1.2.3 Solid Phase Extraction
8.1.3 Market Forecast
8.2 Sample Analysis
8.2.1 Market Trends
8.2.2 Key Segments
8.2.2.1 Hyphenated Technique
8.2.2.2 Chromatographic Technique
8.2.2.3 Electrophoresis
8.2.2.4 Ligand Binding Assay
8.2.2.5 Mass Spectrometry
8.2.2.6 Nuclear Magnetic Resonance
8.2.3 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Almac Group
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 Charles River Laboratories International Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Frontage Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 ICON plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Intertek Group plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Laboratory Corporation of America Holdings
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Pace Analytical Services LLC
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 PPD Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 PRA Health Sciences
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
14.3.10 SGS SA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Syneos Health
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Toxikon Corporation
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio

Companies Mentioned

  • Almac Group
  • Charles River Laboratories International Inc.
  • Frontage Laboratories Inc.
  • ICON plc
  • Intertek Group plc
  • Laboratory Corporation of America Holdings
  • Pace Analytical Services LLC
  • PPD Inc.
  • PRA Health Sciences
  • SGS SA
  • Syneos Health
  • Toxikon Corporation

Methodology

Loading
LOADING...

Table Information